法国全科医生对多病共存患者多重用药与治疗困境的管理:一项横断面调查
该研究于2016年对法国1266名随机抽取的私人执业全科医生进行横断面调查,使用标准化问卷和包含8个版本的临床情景案例,探讨全科医生在多病共存和/或多重用药患者中处方与deprescribing的态度及相关因素。结果显示91.4%的应答者对deprescribing不适当药物感到舒适或较舒适,但仅34.7%经常或很经常决定这样做;在情景案例中,当患者要求酮洛芬时,94.1%认为处方有风险,但25.6%仍会处方,且对老年患者和有卒中史者处方可能性更低。结论指出部分全科医生在治疗困境中优先考虑患者要求而非医源性风险,需要实用工具和技能提升。
要点
- 91.4%全科医生对deprescribing不适当药物感到舒适,但仅34.7%经常实践。
- 情景中94.1%认为患者要求酮洛芬有风险,但25.6%仍会处方。
- 对老年患者(AOR 0.48)和有卒中史者(AOR 0.55)处方酮洛芬可能性更低。
核心结论
- 在治疗困境中,部分全科医生选择优先满足患者要求而非规避医源性风险。
- 全科医生需要实用的实施工具来处理治疗困境,并提升药物管理和患者参与技能。
研究设计与样本
- 2016年法国私人执业全科医生全国性横断面调查,从1266名随机抽取的全科医生中收集数据。
- 使用标准化问卷,包含一个关于女性多病共存患者的临床情景案例,随机分配8个版本(变化患者年龄、社会职业状况和卒中史)。
- 采用向后选择法识别与全科医生对不适当药物决策相关的因素。
主要发现
- 91.4%的应答者对deprescribing不适当药物感到舒适或较舒适,但仅34.7%经常或很经常决定这样做。
- 在临床情景中,大多数全科医生因风险受益比不利而选择停用对症药物(如苯二氮䓬类、对乙酰氨基酚/曲马多)。
- 当患者要求酮洛芬治疗持续性坐骨神经痛时,94.1%认为该处方有风险,但25.6%仍会处方。
- 对老年患者处方酮洛芬的可能性更低(AOR 0.48,95%CI 0.36-0.63),对有卒中史者也更低(AOR 0.55,95%CI 0.42-0.72)。
关键数值与推荐
- 91.4%全科医生对deprescribing感到舒适或较舒适,34.7%经常或很经常实践。
- 94.1%认为患者要求的酮洛芬处方有风险,25.6%仍会处方。
- 老年患者AOR 0.48(95%CI 0.36-0.63),卒中史患者AOR 0.55(95%CI 0.42-0.72)。
临床怎么用
- 全科医生应意识到在治疗困境中可能优先满足患者要求而忽视医源性风险。
- 处理多重用药和多病共存时,需使用实用工具支持deprescribing决策。
- 应加强药物管理技能和患者参与治疗决策的沟通能力。
局限性
- 研究为横断面调查,无法推断因果关系。
- 基于临床情景案例的决策可能不完全反映真实临床实践。
- 样本仅限法国私人执业全科医生,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: GPs are confronted with therapeutic dilemmas in treating patients with multimorbidity and/or polypharmacy when unfavourable medication risk-benefit ratios (RBRs) conflict with patients' demands. AIM: To understand GPs' attitudes about prescribing and/or deprescribing medicines for patients with multimorbidity and/or polypharmacy, and factors associated with their decisions. DESIGN AND SETTING: Cross-sectional survey in 2016 among a national panel of 1266 randomly selected GPs in private practice in France. METHOD: GPs' opinions and attitudes were explored using a standardised questionnaire including a case vignette about a female treated for multiple somatic diseases, sleeping disorders, and chronic pain. Participants were randomly assigned one of eight versions of this case vignette, varying by patient age, socioprofessional status, and stroke history. Backward selection was used to identify factors associated with GPs' decisions about drugs they considered inappropriate. RESULTS: Nearly all (91.4%) responders felt comfortable or fairly comfortable deprescribing inappropriate medications, but only 34.7% decided to do so often or very often. In the clinical vignette, most GPs chose to discontinue symptomatic medications (for example, benzodiazepine, paracetamol/tramadol) because of unfavourable RBRs. When patients asked for ketoprofen for persistent sciatica, 94.1% considered this prescription risky, but 25.6% would prescribe it. They were less likely to prescribe it to older patients (adjusted odds ratio [AOR] 0.48, 95% confidence interval [CI] = 0.36 to 0.63), or those with a stroke history (AOR 0.55, 95% CI = 0.42 to 0.72). CONCLUSION: In therapeutic dilemmas, some GPs choose to prioritise patients' requests over iatrogenic risks. GPs need pragmatic implementation tools for handling therapeutic dilemmas, and to improve their skills in medication management and patient engagement in such situations.
引用
- Carrier H, Zaytseva A, Bocquier A, et al. GPs' management of polypharmacy and therapeutic dilemma in patients with multimorbidity: a cross-sectional survey of GPs in France. Br J Gen Pract. 2019. PMID: 30803978. doi:10.3399/bjgp19X701801
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。